Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
First-in-Human Study of the Biodistribution and Pharmacokinetics of 89Zr-CX-072, a Novel Immunopet Tracer Based on an Anti-PD-L1 Probody.
Clin Cancer Res. 2021 Oct 1;27(19):5325-5333. doi: 10.1158/1078-0432.CCR-21-0453.
Clin Cancer Res. 2021.
PMID: 34253583
Interleukin-2 PET imaging in patients with metastatic melanoma before and during immune checkpoint inhibitor therapy.
van de Donk PP, Wind TT, Hooiveld-Noeken JS, van der Veen EL, Glaudemans AWJM, Diepstra A, Jalving M, de Vries EGE, de Vries EFJ, Hospers GAP.
van de Donk PP, et al. Among authors: hooiveld noeken js.
Eur J Nucl Med Mol Imaging. 2021 Dec;48(13):4369-4376. doi: 10.1007/s00259-021-05407-y. Epub 2021 Jun 2.
Eur J Nucl Med Mol Imaging. 2021.
PMID: 34076745
Free PMC article.
Item in Clipboard
Driving innovation for rare skin cancers: utilizing common tumours and machine learning to predict immune checkpoint inhibitor response.
Hooiveld-Noeken JS, Fehrmann RSN, de Vries EGE, Jalving M.
Hooiveld-Noeken JS, et al.
Immunooncol Technol. 2019 Nov 27;4:1-7. doi: 10.1016/j.iotech.2019.11.002. eCollection 2019 Dec.
Immunooncol Technol. 2019.
PMID: 35755000
Free PMC article.
Review.
Item in Clipboard
Towards less mutilating treatments in patients with advanced non-melanoma skin cancers by earlier use of immune checkpoint inhibitors.
Hooiveld-Noeken JS, Eggen AC, Rácz E, de Vries EGE, Reyners AKL, Jalving M.
Hooiveld-Noeken JS, et al.
Crit Rev Oncol Hematol. 2022 Dec;180:103855. doi: 10.1016/j.critrevonc.2022.103855. Epub 2022 Oct 17.
Crit Rev Oncol Hematol. 2022.
PMID: 36257534
Free article.
Review.
Item in Clipboard
Total serum N-glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanoma.
Visconti A, Rossi N, Deriš H, Lee KA, Hanić M, Trbojević-Akmačić I, Thomas AM, Bolte LA, Björk JR, Hooiveld-Noeken JS, Board R, Harland M, Newton-Bishop J, Harries M, Sacco JJ, Lorigan P, Shaw HM, de Vries EGE, Fehrmann RSN, Weersma RK, Spector TD, Nathan P, Hospers GAP, Sasieni P, Bataille V, Lauc G, Falchi M.
Visconti A, et al. Among authors: hooiveld noeken js.
BMC Cancer. 2023 Feb 18;23(1):166. doi: 10.1186/s12885-023-10511-3.
BMC Cancer. 2023.
PMID: 36805683
Free PMC article.
Item in Clipboard
Whole-body CD8+ T cell visualization before and during cancer immunotherapy: a phase 1/2 trial.
Kist de Ruijter L, van de Donk PP, Hooiveld-Noeken JS, Giesen D, Elias SG, Lub-de Hooge MN, Oosting SF, Jalving M, Timens W, Brouwers AH, Kwee TC, Gietema JA, Fehrmann RSN, Fine BM, Sanabria Bohórquez SM, Yadav M, Koeppen H, Jing J, Guelman S, Lin MT, Mamounas MJ, Eastham JR, Kimes PK, Williams SP, Ungewickell A, de Groot DJA, de Vries EGE.
Kist de Ruijter L, et al. Among authors: hooiveld noeken js.
Nat Med. 2022 Dec;28(12):2601-2610. doi: 10.1038/s41591-022-02084-8. Epub 2022 Dec 5.
Nat Med. 2022.
PMID: 36471036
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite